LKST
Leukosite Inc
Biopharmaceutical company developing monoclonal antibody therapies for oncology and inflammatory diseases; acquired by Millennium Pharmaceuticals in December 1999
CUSIP: 52728R102HealthcareUS1 holder
Leukosite Inc
Biopharmaceutical company developing monoclonal antibody therapies for oncology and inflammatory diseases; acquired by Millennium Pharmaceuticals in December 1999
No insider transactions reported in the last 6 months. Look across all recorded history →